Clinical trial

Daily Oral L-arginine Plus Tadalafil in Diabetic Patients With Erectile Dysfunction

NCT03834610

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-10-01

PhaseNA

Study timeline

Study start (actual)2017-10-01Date precision: day

Registry last updated2019-02-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Erectile Dysfunctionunresolved

Interventions

L-arginine 5 gm oral capsDRUG

Tadalafil 10 MGDRUG · verified · RxNorm: tadalafil 10 MG

serum testosterone levelDIAGNOSTIC_TEST

HbA1CDIAGNOSTIC_TEST

penile dopplerDEVICE

Sponsors & collaborators

Aswan University Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03834610 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.